Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neurosurgery

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 195 articles:
HTML format



Single Articles


    November 2021
  1. ITO K, Sugita S, Nakajima Y, Furuya T, et al
    Phase II Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


    October 2021
  2. RABEN D, Raben A
    A Two-Headed Heated Debate.
    Int J Radiat Oncol Biol Phys. 2021;111:310.
    PubMed    


  3. PERDOMO-PANTOJA A, Holmes C, Lina IA, Liauw JA, et al
    Effects of Single-Dose Versus Hypofractionated Focused Radiation on Vertebral Body Structure and Biomechanical Integrity: Development of a Rabbit Radiation-Induced Vertebral Compression Fracture Model.
    Int J Radiat Oncol Biol Phys. 2021;111:528-538.
    PubMed     Abstract available


    September 2021
  4. NAGAR H, Spratt DE
    Prostate SBRT Dose Escalation (9 Gyx5, 13.3 Gyx3, 24 Gyx1): Are We Making Progress?
    Int J Radiat Oncol Biol Phys. 2021;111:110-112.
    PubMed    


  5. REDMOND KJ, De Salles AAF, Fariselli L, Levivier M, et al
    Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
    Int J Radiat Oncol Biol Phys. 2021;111:68-80.
    PubMed     Abstract available


  6. JACKSON WC, Hartman HE, Gharzai LA, Maurino C, et al
    The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:127-134.
    PubMed     Abstract available


  7. BROWNSTEIN J, Afzal M, Okabe T, Harfi TT, et al
    Method and Atlas to Enable Targeting for Cardiac Radioablation Employing the American Heart Association Segmented Model.
    Int J Radiat Oncol Biol Phys. 2021;111:178-185.
    PubMed     Abstract available


  8. MAGALLON-BARO A, Milder MTW, Granton PV, Nuyttens JJ, et al
    Comparison of Daily Online Plan Adaptation Strategies for a Cohort of Pancreatic Cancer Patients Treated with SBRT.
    Int J Radiat Oncol Biol Phys. 2021;111:208-219.
    PubMed     Abstract available


    August 2021
  9. ITO K, Ogawa H
    Stereotactic Body Radiation Therapy for Patients With Sacral Chordoma Who Previously Received Carbon Ion Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1263-1264.
    PubMed    


  10. MOORE C, Hsu CC, Chen WM, Chen BPC, et al
    Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade.
    Int J Radiat Oncol Biol Phys. 2021;110:1306-1316.
    PubMed     Abstract available


  11. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    PubMed     Abstract available


    July 2021
  12. ITO K, Sugita S, Nakajima Y, Furuya T, et al
    Phase II clinical trial of separation surgery followed by stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Int J Radiat Oncol Biol Phys. 2021 Jul 23. pii: S0360-3016(21)02560.
    PubMed     Abstract available


  13. SOYFER V, Gutfeld O, Shamai S, Schlocker A, et al
    COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
    Int J Radiat Oncol Biol Phys. 2021;110:957-961.
    PubMed     Abstract available


  14. CHOUDHURY A, Henry Md Frcr A, Mitin Md PhD T, Chen Md Mph R, et al
    Photons, Protons, SBRT, Brachytherapy-What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team.
    Int J Radiat Oncol Biol Phys. 2021;110:1114-1121.
    PubMed    


  15. COURTNEY PT, Paravati AJ, Atwood TF, Raja N, et al
    Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:1003-1012.
    PubMed     Abstract available


  16. MARGULIS V, Freifeld Y, Pop LM, Manna S, et al
    Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:1135-1142.
    PubMed     Abstract available


  17. BISWAS T, Spratt DE
    Dose Escalation for Oligometastatic Disease: Is More Better?
    Int J Radiat Oncol Biol Phys. 2021;110:680-681.
    PubMed    


  18. BODA-HEGGEMANN J, Blanck O, Mehrhof F, Ernst F, et al
    Interdisciplinary Clinical Target Volume Generation for Cardiac Radioablation: Multicenter Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:745-756.
    PubMed     Abstract available


  19. VAN DAMS R, Jiang NY, Fuller DB, Loblaw A, et al
    Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
    Int J Radiat Oncol Biol Phys. 2021;110:731-737.
    PubMed     Abstract available


  20. ZELEFSKY MJ, Yamada Y, Greco C, Lis E, et al
    Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:672-679.
    PubMed     Abstract available


    June 2021
  21. HOSKIN MD FRCR P
    Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2, Randomized Controlled Trial Within a Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2021;110:368-370.
    PubMed    


  22. GUCKENBERGER M, Mantel F, Sweeney RA, Hawkins M, et al
    Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Int J Radiat Oncol Biol Phys. 2021;110:348-357.
    PubMed     Abstract available


  23. PARK JH, Kim HY, Lee A, Seo YK, et al
    Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.
    Int J Radiat Oncol Biol Phys. 2021;110:510-520.
    PubMed     Abstract available


  24. PIELKENROOD BJ, van der Velden JM, van der Linden YM, Bartels MMT, et al
    Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2021;110:358-367.
    PubMed     Abstract available


    May 2021
  25. VIDETIC GMM, Reddy CA, Woody NM, Stephans KL, et al
    Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00658.
    PubMed     Abstract available


  26. STUMPF PK, Yorke ED, El Naqa I, Cuneo KC, et al
    Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors.
    Int J Radiat Oncol Biol Phys. 2021;110:217-226.
    PubMed     Abstract available


  27. GRIMM J, Marks LB, Jackson A, Kavanagh BD, et al
    High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview.
    Int J Radiat Oncol Biol Phys. 2021;110:1-10.
    PubMed    


  28. GRIMM J, Vargo JA, Mavroidis P, Moiseenko V, et al
    Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Int J Radiat Oncol Biol Phys. 2021;110:147-159.
    PubMed     Abstract available


  29. SOLTYS SG, Grimm J, Milano MT, Xue J, et al
    Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Int J Radiat Oncol Biol Phys. 2021;110:112-123.
    PubMed     Abstract available


  30. MAHADEVAN A, Moningi S, Grimm J, Li XA, et al
    Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:206-216.
    PubMed     Abstract available


  31. WANG K, Mavroidis P, Royce TJ, Falchook AD, et al
    Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.
    Int J Radiat Oncol Biol Phys. 2021;110:237-248.
    PubMed     Abstract available


  32. MILANO MT, Grimm J, Niemierko A, Soltys SG, et al
    Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Int J Radiat Oncol Biol Phys. 2021;110:68-86.
    PubMed     Abstract available


  33. SAHGAL A, Chang JH, Ma L, Marks LB, et al
    Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:124-136.
    PubMed     Abstract available


  34. LEE P, Loo BW Jr, Biswas T, Ding GX, et al
    Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:160-171.
    PubMed     Abstract available


  35. MARCISCANO AE, Haimovitz-Friedman A, Lee P, Tran PT, et al
    Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:35-52.
    PubMed    


  36. SONG CW, Glatstein E, Marks LB, Emami B, et al
    Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
    Int J Radiat Oncol Biol Phys. 2021;110:21-34.
    PubMed     Abstract available


  37. KONG FS, Moiseenko V, Zhao J, Milano MT, et al
    Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
    Int J Radiat Oncol Biol Phys. 2021;110:172-187.
    PubMed     Abstract available


  38. MILANO MT, Grimm J, Soltys SG, Yorke E, et al
    Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
    Int J Radiat Oncol Biol Phys. 2021;110:87-99.
    PubMed     Abstract available


  39. MIFTEN M, Vinogradskiy Y, Moiseenko V, Grimm J, et al
    Radiation Dose-Volume Effects for Liver SBRT.
    Int J Radiat Oncol Biol Phys. 2021;110:196-205.
    PubMed     Abstract available


  40. OHRI N, Tome WA, Mendez Romero A, Miften M, et al
    Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.
    Int J Radiat Oncol Biol Phys. 2021;110:188-195.
    PubMed     Abstract available


    April 2021
  41. TATEISHI Y, Takeda A, Horita N, Tsurugai Y, et al
    Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 20. pii: S0360-3016(21)00375.
    PubMed     Abstract available


  42. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed     Abstract available


  43. FOLKERT MR, Meyer JJ, Aguilera TA, Yokoo T, et al
    Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1387-1395.
    PubMed     Abstract available


  44. QU XM, Chen Y, Zaric GS, Senan S, et al
    Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1176-1184.
    PubMed     Abstract available


  45. MERCIER C, Claessens M, Buys MSc A, Gryshkevych S, et al
    Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1195-1205.
    PubMed     Abstract available


  46. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    PubMed     Abstract available


  47. TINKLE CL, Singh C, Lloyd S, Guo Y, et al
    Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
    Int J Radiat Oncol Biol Phys. 2021;109:1396-1405.
    PubMed     Abstract available


  48. ZHANG J, Wang L, Li X, Huang M, et al
    Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking.
    Int J Radiat Oncol Biol Phys. 2021;109:1588-1605.
    PubMed     Abstract available


  49. KUMAR A, Straka C, Courtney PT, Vitzthum L, et al
    Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;109:1185-1194.
    PubMed     Abstract available


    March 2021
  50. MAGLI A, Farneti A, Faiella A, Ferriero M, et al
    Toxicity at 1 year after Stereotactic Body Radiotherapy in 3 Fractions for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 18. pii: S0360-3016(21)00287.
    PubMed     Abstract available


  51. SANTOS PMG, Lapen K, Zhang Z, Lobaugh S, et al
    Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation.
    Int J Radiat Oncol Biol Phys. 2021;109:923-931.
    PubMed     Abstract available


  52. ZHANG J, Wang C, Sheng Y, Palta M, et al
    An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1076-1085.
    PubMed     Abstract available


  53. LYDIARD PGDIP S, Blanck O, Hugo G, O'Brien R, et al
    A Review of Cardiac Radioablation (CR) for Arrhythmias: Procedures, Technology, and Future Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;109:783-800.
    PubMed     Abstract available


  54. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


  55. SOGONO P, Bressel M, David S, Shaw M, et al
    Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
    Int J Radiat Oncol Biol Phys. 2021;109:756-763.
    PubMed     Abstract available


    February 2021
  56. KOWALCHUK RO, Shepard MJ, Sheehan K, Sheehan D, et al
    Treatment of WHO grade II meningiomas with stereotactic radiosurgery: identification of an optimal group for SRS using RPA.
    Int J Radiat Oncol Biol Phys. 2021 Feb 3. pii: S0360-3016(21)00122.
    PubMed     Abstract available


  57. DUNNE EM, Liu M
    Postoperative Stereotactic Body Radiation Therapy, Then Observe.
    Int J Radiat Oncol Biol Phys. 2021;109:316.
    PubMed    


  58. DE BARI B
    Cautious SBRT.
    Int J Radiat Oncol Biol Phys. 2021;109:315.
    PubMed    


  59. KIM N, Cheng J, Huang WY, Kimura T, et al
    Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.
    Int J Radiat Oncol Biol Phys. 2021;109:464-473.
    PubMed     Abstract available


  60. LO CH, Lee HL, Hsiang CW, Chiou JF, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:474-484.
    PubMed     Abstract available


    January 2021
  61. SALAMA JK, Giuliani ME, Robinson CG, Daly ME, et al
    Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"?
    Int J Radiat Oncol Biol Phys. 2021;109:1-4.
    PubMed    


  62. JACKSON WC, Tang M, Maurino C, Mendiratta-Lala M, et al
    Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.
    Int J Radiat Oncol Biol Phys. 2021;109:212-219.
    PubMed     Abstract available


    December 2020
  63. REDMOND KJ, Gui C, Benedict S, Milano MT, et al
    Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Dec 31. pii: S0360-3016(20)34451.
    PubMed     Abstract available


  64. CHEN WC, Li Y, Lazar A, Altan A, et al
    Stereotactic body radiotherapy and high-dose rate brachytherapy boost in combination with intensity modulated radiotherapy for localized prostate cancer: a single-institution propensity score matched analysis.
    Int J Radiat Oncol Biol Phys. 2020 Dec 29. pii: S0360-3016(20)34730.
    PubMed     Abstract available


  65. SOLTYS SG, Milano MT, Xue J, Tome WA, et al
    Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Int J Radiat Oncol Biol Phys. 2020 Dec 26. pii: S0360-3016(20)34541.
    PubMed     Abstract available


  66. MCDONALD BA, Vedam S, Yang J, Wang J, et al
    Initial Feasibility and Clinical Implementation of Daily MR-guided Adaptive Head and Neck Cancer Radiotherapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34661.
    PubMed     Abstract available


  67. JIAO Z, Li H, Xiao Y, Aggarwal C, et al
    Integration of risk survival measures estimated from pre- and post-treatment CT scans improves stratification of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34660.
    PubMed     Abstract available


  68. TANG C, Lei X, Smith GL, Pan HY, et al
    Influence of Geography on Prostate Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2020 Dec 11. pii: S0360-3016(20)34595.
    PubMed     Abstract available


  69. KIMURA T, Takeda A, Tsurugai Y, Kawano R, et al
    A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1265-1275.
    PubMed     Abstract available


  70. SEBASTIAN NT, Miller ED, Yang X, Diaz DA, et al
    A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1276-1283.
    PubMed     Abstract available


  71. DEE EC, Muralidhar V, Arega MA, Kishan AU, et al
    Factors influencing non-completion of radiotherapy among men with localized prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Dec 1. pii: S0360-3016(20)34604.
    PubMed     Abstract available


    November 2020
  72. SPENCER KL, Tree AC
    Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:927-929.
    PubMed    


  73. BURRI SH, Ward MC, Prabhu RS
    Hobgoblins, Iron Lungs, and Surgical Perturbation Failure?
    Int J Radiat Oncol Biol Phys. 2020;108:996-998.
    PubMed    


  74. VASQUEZ OSORIO EM, McCallum H, Bedair A, Faivre-Finn C, et al
    Protecting the Heart: A Practical Approach to Account for the Full Extent of Heart Motion in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2020;108:1082-1090.
    PubMed     Abstract available


  75. PARIKH NR, Kundu P, Levin-Epstein R, Chang EM, et al
    Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Using Single-Isocenter Versus Multiple-Isocenter Technique.
    Int J Radiat Oncol Biol Phys. 2020;108:999-1007.
    PubMed     Abstract available


  76. SIVA S, Correa RJM, Warner A, Staehler M, et al
    Stereotactic Ablative Radiotherapy for >/=T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Int J Radiat Oncol Biol Phys. 2020;108:941-949.
    PubMed     Abstract available


  77. GOGINENI E, Rana Z, Soberman D, Sidiqi B, et al
    Biochemical control and toxicity outcomes of SBRT vs LDR brachytherapy in the treatment of low and intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 7. pii: S0360-3016(20)34489.
    PubMed     Abstract available


  78. JOHNSTONE C, Recht A
    It's Time...
    Int J Radiat Oncol Biol Phys. 2020;108:572-574.
    PubMed    


  79. YU JB, Brock KK, Campbell AM, Chen AB, et al
    Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop.
    Int J Radiat Oncol Biol Phys. 2020;108:539-545.
    PubMed     Abstract available


  80. BYUN HK, Yoon HI, Cho J, Shim KW, et al
    Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone with Reduced Volume and Dose.
    Int J Radiat Oncol Biol Phys. 2020;108:657-666.
    PubMed     Abstract available


    October 2020
  81. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed    


    September 2020
  82. SANDERS JW, Venkatesan AM, Levitt CA, Bathala T, et al
    Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study.
    Int J Radiat Oncol Biol Phys. 2020 Sep 24. pii: S0360-3016(20)34342.
    PubMed     Abstract available


  83. ROYCE TJ, Mavroidis P, Wang K, Falchook AD, et al
    Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Sep 5. pii: S0360-3016(20)34102.
    PubMed     Abstract available


  84. KORPICS MC, Polley MY, Bhave SR, Redler G, et al
    A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab.
    Int J Radiat Oncol Biol Phys. 2020;108:189-195.
    PubMed     Abstract available


  85. RATNAYAKE G, Reinwald S, Shackleton M, Moore M, et al
    Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:150-156.
    PubMed     Abstract available


  86. TIAN S, Switchenko JM, Buchwald ZS, Patel PR, et al
    Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2020;108:304-313.
    PubMed     Abstract available


    July 2020
  87. BERGAMIN S, Eade T, Kneebone A, Booth J, et al
    Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jul 10. pii: S0360-3016(20)31412.
    PubMed     Abstract available


  88. SANDERS JW, Lewis GD, Thames HD, Kudchadker RJ, et al
    Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jul 4. pii: S0360-3016(20)31396.
    PubMed     Abstract available


  89. TSANG RW, Laperriere N
    Whole Brain Radiation Is Still the Standard in the Salvage Situation.
    Int J Radiat Oncol Biol Phys. 2020;107:403.
    PubMed    


  90. BERTHO A, Dos Santos M, Buard V, Paget V, et al
    Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Effect of Beam Size Changes and Dose Effect at Constant Collimation.
    Int J Radiat Oncol Biol Phys. 2020;107:548-562.
    PubMed     Abstract available


    June 2020
  91. HELIS CA, Hughes RT, Glenn CW, Lanier CM, et al
    Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy.
    Int J Radiat Oncol Biol Phys. 2020 Jun 29. pii: S0360-3016(20)31344.
    PubMed     Abstract available


  92. PARIKH NR, Kishan AU, Kane N, Diaz-Perez S, et al
    Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 17. pii: S0360-3016(20)31251.
    PubMed     Abstract available


  93. PARIKH NR, Chang EM, Nickols NG, Rettig MB, et al
    Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31250.
    PubMed     Abstract available


  94. JACCARD M, Zilli T, Dubouloz A, Escude L, et al
    Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.
    Int J Radiat Oncol Biol Phys. 2020 Jun 11. pii: S0360-3016(20)31242.
    PubMed     Abstract available


  95. CHANG DT, Pollom EL, Keane FK, Wo JY, et al
    Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?
    Int J Radiat Oncol Biol Phys. 2020;107:257-260.
    PubMed    


  96. PALMA DA, Bauman GS, Rodrigues GB
    Beyond Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;107:253-256.
    PubMed    


  97. FINAZZI T, Haasbeek CJA, Spoelstra FOB, Palacios MA, et al
    Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2020;107:270-278.
    PubMed     Abstract available


  98. AYOUB Z, Ning MS, Brooks ED, Kang J, et al
    Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:261-269.
    PubMed     Abstract available


    May 2020
  99. HASEGAWA T, Kato T, Naito T, Tanei T, et al
    Long-term outcomes of sporadic vestibular schwannomas treated with recent stereotactic radiosurgery techniques.
    Int J Radiat Oncol Biol Phys. 2020 May 28. pii: S0360-3016(20)31186.
    PubMed     Abstract available


  100. CHU C, Davis CM, Lan X, Hienz RD, et al
    Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease.
    Int J Radiat Oncol Biol Phys. 2020 May 26. pii: S0360-3016(20)31151.
    PubMed     Abstract available


  101. RAHIMI A, Zhang Y, Kim DW, Morgan H, et al
    Risk factors for fat necrosis after stereotactic partial breast irradiation (S-PBI) for early stage breast cancer in a phase I clinical trial.
    Int J Radiat Oncol Biol Phys. 2020 May 25. pii: S0360-3016(20)31149.
    PubMed     Abstract available


  102. LIU Q, Zhu Z, Chen Y, Deng J, et al
    Phase II Study of SBRT for Patients With Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 May 14. pii: S0360-3016(20)31127.
    PubMed     Abstract available


  103. KASMANN L, Eze C, Manapov F
    Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
    Int J Radiat Oncol Biol Phys. 2020 May 12. pii: S0360-3016(20)30987.
    PubMed    


  104. VAN DE VEN S, van den Bongard D, Pielkenrood B, Kasperts N, et al
    Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.
    Int J Radiat Oncol Biol Phys. 2020;107:39-47.
    PubMed     Abstract available


  105. CHEN WC, Baal JD, Baal U, Pai J, et al
    Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients.
    Int J Radiat Oncol Biol Phys. 2020;107:48-61.
    PubMed     Abstract available


  106. ALAYED Y, Davidson M, Liu S, Chu W, et al
    Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2020;107:136-142.
    PubMed     Abstract available


  107. GUO T, Ni J, Yang X, Li Y, et al
    Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:62-71.
    PubMed     Abstract available


    April 2020
  108. HRYCUSHKO B, van der Kogel AJ, Phillips L, Folkert M, et al
    Existence of a Dose-Length Effect in Spinal Nerves Receiving Single-Session Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:1010-1016.
    PubMed     Abstract available


    March 2020
  109. ALBUQUERQUE K, Timmerman R
    In Reply to Dalwadi et al.
    Int J Radiat Oncol Biol Phys. 2020;106:889.
    PubMed    


  110. DALWADI SM, Bonnen MD, Ludwig MS
    In Regard to Albuquerque et al.
    Int J Radiat Oncol Biol Phys. 2020;106:888-889.
    PubMed    


  111. KLEMENT RJ, Sonke JJ, Allgauer M, Andratschke N, et al
    Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.
    Int J Radiat Oncol Biol Phys. 2020 Mar 15. pii: S0360-3016(20)30897.
    PubMed     Abstract available


  112. KIRKPATRICK JP
    Classifying Leptomeningeal Disease: An Essential Element in Managing Advanced Metastatic Disease in the Central Nervous System.
    Int J Radiat Oncol Biol Phys. 2020;106:587-588.
    PubMed    


  113. VAN MARLEN P, Dahele M, Folkerts M, Abel E, et al
    Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
    Int J Radiat Oncol Biol Phys. 2020;106:621-629.
    PubMed     Abstract available


  114. SAMPATH S, Frankel P, Vecchio BD, Ruel N, et al
    Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2020;106:537-545.
    PubMed     Abstract available


  115. REYNOLDS TA, Jensen AR, Bellairs EE, Ozer M, et al
    Dose Gradient Index for Stereotactic Radiosurgery/Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:604-611.
    PubMed     Abstract available


  116. KAMRAVA M, Chino JP, Beriwal S
    SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Int J Radiat Oncol Biol Phys. 2020;106:472-474.
    PubMed    


  117. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
    Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;106:455-459.
    PubMed    


    February 2020
  118. GIGLIOLI FR, Garibaldi C, Blanck O, Villaggi E, et al
    Dosimetric Multicenter Planning Comparison Studies for Stereotactic Body Radiation Therapy: Methodology and Future Perspectives.
    Int J Radiat Oncol Biol Phys. 2020;106:403-412.
    PubMed     Abstract available


  119. TENDLER II, Hartford A, Jermyn M, LaRochelle E, et al
    Experimentally Observed Cherenkov Light Generation in the Eye During Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:422-429.
    PubMed     Abstract available


  120. MACDONALD RL, Lee Y, Schasfoort J, Soliman H, et al
    Real-Time Infrared Motion Tracking Analysis for Patients Treated With Gated Frameless Image Guided Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2020;106:413-421.
    PubMed     Abstract available


  121. TRIFILETTI DM, Ballman KV, Brown PD, Anderson SK, et al
    Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
    Int J Radiat Oncol Biol Phys. 2020;106:255-260.
    PubMed     Abstract available


  122. FULLER D, Wurzer J, Shirazi R, Bridge S, et al
    Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
    Int J Radiat Oncol Biol Phys. 2020;106:291-299.
    PubMed     Abstract available


  123. REDMOND KJ, Sciubba D, Khan M, Gui C, et al
    A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2020;106:261-268.
    PubMed     Abstract available


    January 2020
  124. DAUTRUCHE A, Filion E, Mathieu D, Bahig H, et al
    To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30124.
    PubMed     Abstract available


  125. MANYAM BV, Verdecchia K, Videtic GMM, Zhuang T, et al
    Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30068.
    PubMed     Abstract available


  126. FARUQI S, Ruschin M, Soliman H, Myrehaug S, et al
    Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Jan 9. pii: S0360-3016(19)34476.
    PubMed     Abstract available


  127. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    In Reply to Mendenhall et al.
    Int J Radiat Oncol Biol Phys. 2020;106:221.
    PubMed    


  128. MENDENHALL WM, Holtzman AL, Dagan R, Bryant CM, et al
    In Regard to Sher et al.
    Int J Radiat Oncol Biol Phys. 2020;106:220-221.
    PubMed    


  129. MESKO S, Wang H, Tung S, Wang C, et al
    Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.
    Int J Radiat Oncol Biol Phys. 2020;106:185-193.
    PubMed     Abstract available


  130. DUIJM M, van der Voort van Zyp NC, van de Vaart P, Oomen-de Hoop E, et al
    Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Int J Radiat Oncol Biol Phys. 2020;106:73-81.
    PubMed     Abstract available


  131. LI R, Shinde A, Novak J, Vapiwala N, et al
    Temporal Trends of Resident Experience in External Beam Radiation Therapy Cases: Analysis of ACGME Case Logs from 2007 to 2018.
    Int J Radiat Oncol Biol Phys. 2020;106:37-42.
    PubMed     Abstract available


    December 2019
  132. RADES D, Cacicedo J, Conde-Moreno AJ, Segedin B, et al
    Precision radiotherapy for metastatic spinal cord compression: Final results of the PRE-MODE Trial.
    Int J Radiat Oncol Biol Phys. 2019 Dec 5. pii: S0360-3016(19)34460.
    PubMed     Abstract available


  133. KIRKPATRICK JP, Fecci PE
    Offer Hypofractionated SRS... If Her Performance Status Is Good.
    Int J Radiat Oncol Biol Phys. 2019;105:940-941.
    PubMed    


  134. LI R, Vora N
    Radiation Therapy for Surgically Resected Brain Metastasis: What Is Your Approach?
    Int J Radiat Oncol Biol Phys. 2019;105:938-939.
    PubMed    


  135. HARDY-ABELOOS C, Lazarev S, Ru M, Kim E, et al
    Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Int J Radiat Oncol Biol Phys. 2019;105:968-976.
    PubMed     Abstract available


  136. OLSON R, Senan S, Harrow S, Gaede S, et al
    Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019;105:943-947.
    PubMed     Abstract available


    November 2019
  137. SHI S, Sandhu N, Jin MC, Wang E, et al
    Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.
    Int J Radiat Oncol Biol Phys. 2019 Nov 27. pii: S0360-3016(19)34058.
    PubMed     Abstract available


  138. ALBUQUERQUE K, Tumati V, Lea J, Ahn C, et al
    A Phase II Trial of Stereotactic Ablative Radiotherapy as a Boost for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Nov 4. pii: S0360-3016(19)33966.
    PubMed     Abstract available


  139. MITIN T, Henry A, Choudhury A, Chen RC, et al
    SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?
    Int J Radiat Oncol Biol Phys. 2019;105:618-620.
    PubMed    


  140. SPENCER K, Velikova G, Henry A, Westhoff P, et al
    Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study.
    Int J Radiat Oncol Biol Phys. 2019;105:559-566.
    PubMed     Abstract available


  141. JIANG NY, Dang AT, Yuan Y, Chu FI, et al
    Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;105:628-636.
    PubMed     Abstract available


    October 2019
  142. SHEPARD MJ, Sheehan JP
    The Choice of Postoperative Stereotactic Radiosurgery After Resection of an Isolated Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2019 Oct 24. pii: S0360-3016(18)30959.
    PubMed    


  143. TURNER BE, Prabhu RS, Burri SH, Brown PD, et al
    Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.
    Int J Radiat Oncol Biol Phys. 2019 Oct 9. pii: S0360-3016(19)33867.
    PubMed     Abstract available


  144. PASQUIER D, Peiffert D, Nickers P, Maingon P, et al
    A multicentre phase II study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO trial.
    Int J Radiat Oncol Biol Phys. 2019 Oct 8. pii: S0360-3016(19)33863.
    PubMed     Abstract available


  145. KANG J, Ning MS, Feng H, Li H, et al
    Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms.
    Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33861.
    PubMed     Abstract available


  146. MCCLELLAND S 3RD, Saito NG
    An Intracranial Hemorrhage Wrapped in an Enigma.
    Int J Radiat Oncol Biol Phys. 2019;105:242-243.
    PubMed    


  147. ZHANG Y, Schoenhals J, Christie A, Mohamad O, et al
    Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:367-375.
    PubMed     Abstract available


  148. SHEN PC, Chang WC, Lo CH, Yang JF, et al
    Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019;105:307-318.
    PubMed     Abstract available


    September 2019
  149. OZSAHIN M, Slotman BJ, Bourhis J
    Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;105:233-234.
    PubMed    


  150. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed    


  151. MUELLER AC, Karam SD
    SBRT for Early Stage Larynx: A Go or No Go? It's All in the Delivery.
    Int J Radiat Oncol Biol Phys. 2019;105:119-120.
    PubMed    


  152. KANG BH, Yu T, Kim JH, Park JM, et al
    Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:104-109.
    PubMed     Abstract available


    August 2019
  153. QIAN JM, Yu JB, Mahajan A, Goldberg SB, et al
    Frequent use of local therapy underscores need for multidisciplinary care in the management of patients with melanoma brain metastases treated with PD-1 inhibitors.
    Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33742.
    PubMed     Abstract available


  154. NAVARRIA P, Pessina F, Clerici E, Franceschini D, et al
    Surgery followed by hypofractionated radiosurgery on the tumor bed in oligometastatic patients with large brain metastases. Results of a Phase II study.
    Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33743.
    PubMed     Abstract available


  155. SINGH AK, Gomez-Suescun JA, Stephans KL, Bogart JA, et al
    One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2019 Aug 22. pii: S0360-3016(19)33653.
    PubMed     Abstract available


  156. LIU C, Sun B, Hu X, Zhang Y, et al
    Stereotactic ablative radiotherapy for pulmonary recurrence-based oligometastatic non-small cell lung cancer: survival and prognostic value of regulatory T cells.
    Int J Radiat Oncol Biol Phys. 2019 Aug 19. pii: S0360-3016(19)33646.
    PubMed     Abstract available


  157. BRUYNZEEL AME, Tetar SU, Oei SS, Senan S, et al
    A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33640.
    PubMed     Abstract available


  158. DEEK MP, Yu C, Phillips R, Song DY, et al
    Radiotherapy In The Definitive Management Of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33641.
    PubMed     Abstract available


  159. KNUTSON NC, Samson PP, Hugo GD, Goddu SM, et al
    Radiation Therapy Workflow and Dosimetric Analysis from a Phase 1/2 Trial of Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
    Int J Radiat Oncol Biol Phys. 2019;104:1114-1123.
    PubMed     Abstract available


  160. ONG WL, Foroudi F, Milne RL, Millar JL, et al
    Are We Choosing Wisely in Radiation Oncology Practice-Findings From an Australian Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2019;104:1012-1016.
    PubMed     Abstract available


    July 2019
  161. PASQUIER D, Martinage G, Janoray G, Rojas DP, et al
    Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG.
    Int J Radiat Oncol Biol Phys. 2019 Jul 22. pii: S0360-3016(19)33494.
    PubMed     Abstract available


  162. MOHIDEEN N, Kavanagh BD
    Model Insurance Coverage Policies: The Power of Suggestion, the Force of Evidence.
    Int J Radiat Oncol Biol Phys. 2019;104:745-747.
    PubMed    


  163. HRYCUSHKO B, van der Kogel AJ, Phillips L, Folkert MR, et al
    Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:845-851.
    PubMed     Abstract available


  164. SUNDAHL N, Seremet T, Van Dorpe J, Neyns B, et al
    Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma.
    Int J Radiat Oncol Biol Phys. 2019;104:828-835.
    PubMed     Abstract available


  165. FINAZZI T, Palacios MA, Spoelstra FOB, Haasbeek CJA, et al
    Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2019;104:933-941.
    PubMed     Abstract available


  166. ROACH MC, Thomas TO, Paravati AJ, Mahajan A, et al
    Differences in United States Insurance Payer Policies and American Society for Radiation Oncology's (ASTRO) Model Policy on Stereotactic Body Radiation Therapy (SBRT).
    Int J Radiat Oncol Biol Phys. 2019;104:740-744.
    PubMed     Abstract available


  167. NGUYEN TK, Sahgal A, Detsky J, Soliman H, et al
    Single-Fraction Stereotactic Radiosurgery vs. Hippocampal-Avoidance Whole Brain Radiotherapy for Patients with 10-30 Brain Metastases: A Dosimetric Analysis.
    Int J Radiat Oncol Biol Phys. 2019 Jul 5. pii: S0360-3016(19)33443.
    PubMed     Abstract available


  168. JACKSON WC, Cuneo KC, Lawrence TS, Owen D, et al
    In Reply to Slovak et al.
    Int J Radiat Oncol Biol Phys. 2019;104:696-697.
    PubMed    


  169. WANG TJC
    Hypofractionated Radiation Therapy or Staged Stereotactic Radiosurgery for Large Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2019;104:484-485.
    PubMed    


  170. MENZEL P, Theodosopoulos P
    A Caudate Conundrum.
    Int J Radiat Oncol Biol Phys. 2019;104:481-482.
    PubMed    


  171. SAMPATH S, Rahmanuddin S, Sahoo P, Frankel P, et al
    Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: a prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33424.
    PubMed     Abstract available


    June 2019
  172. VIDETIC GM
    In Reply to Yilmaz et al.
    Int J Radiat Oncol Biol Phys. 2019;104:467.
    PubMed    


  173. YILMAZ MT, Hurmuz P, Cengiz M
    In Regard to Videtic et al.
    Int J Radiat Oncol Biol Phys. 2019;104:466-467.
    PubMed    


  174. LAVIGNE J, Suissa A, Verger N, Dos Santos M, et al
    Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1alpha Endothelial Deletion.
    Int J Radiat Oncol Biol Phys. 2019;104:279-290.
    PubMed     Abstract available


    May 2019
  175. YUAN Y, Aghdam N, King C, Fuller D, et al
    Testosterone Levels and Sexual Quality of Life Following Stereotactic Body Radiotherapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2019 May 17. pii: S0360-3016(19)30727.
    PubMed     Abstract available


  176. WARDAK Z, Bland R, Ahn C, Xie XJ, et al
    A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2019;104:83-89.
    PubMed     Abstract available


  177. ZHU X, Ju X, Cao Y, Shen Y, et al
    Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
    Int J Radiat Oncol Biol Phys. 2019;104:101-110.
    PubMed     Abstract available


  178. FRANCESCHINI D, De Rose F, Franzese C, Comito T, et al
    Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:111-121.
    PubMed     Abstract available


  179. BALLAS LK, Luo C, Chung E, Kishan AU, et al
    Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2019;104:50-60.
    PubMed     Abstract available


    April 2019
  180. ALAYED Y, Loblaw A, Chu W, Al-Hanaqta M, et al
    Stereotactic Body Radiotherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2019 Apr 16. pii: S0360-3016(19)30624.
    PubMed     Abstract available


  181. JACKSON WC, Silva J, Hartman HE, Dess RT, et al
    Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30612.
    PubMed     Abstract available


  182. HUGHES RT, Masters AH, McTyre ER, Farris MK, et al
    Initial SRS for patients with 5-15 brain metastases: results of a multi-institutional experience.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30613.
    PubMed     Abstract available


  183. SIVA S, Ball DL
    Single Fraction SBRT for Early Stage Lung Cancer-Less is More?
    Int J Radiat Oncol Biol Phys. 2019;103:1085-1087.
    PubMed    


  184. RUSTHOVEN CG
    Small Cell Lung Cancer: PCI Uncertainty and Emerging Radiosurgery Interest.
    Int J Radiat Oncol Biol Phys. 2019;103:1034-1035.
    PubMed    


  185. GASPAR LE
    A Gray Zone Regarding Gray Matter.
    Int J Radiat Oncol Biol Phys. 2019;103:1033-1034.
    PubMed    


  186. WEGNER RE, Hasan S
    Observe the Brain and Preserve the Mind.
    Int J Radiat Oncol Biol Phys. 2019;103:1033.
    PubMed    


  187. SHINDE A, Amini A
    Challenging Current Conventions: Up-Front Stereotactic Radiosurgery Alone for Limited Brain Metastases in Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:1031-1032.
    PubMed    


  188. ADAMSON J, Carroll J, Trager M, Yoon SW, et al
    Delivered Dose Distribution Visualized Directly With Onboard kV-CBCT: Proof of Principle.
    Int J Radiat Oncol Biol Phys. 2019;103:1271-1279.
    PubMed     Abstract available


    March 2019
  189. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    Phase I fractional dose escalation study of equipotent stereotactic radiotherapy regimens for early-stage glottic larynx cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 14. pii: S0360-3016(19)30323.
    PubMed     Abstract available


  190. MIYAWAKI E, Kenmotsu H, Mori K, Harada H, et al
    Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-mutant NSCLC with Brain Metastases Stratified by Number of Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2019 Mar 6. pii: S0360-3016(19)30307.
    PubMed     Abstract available


    February 2019
  191. D'AGOSTINO GR, di Brina L, Mancosu P, Franzese C, et al
    Re-Irradiation of Locally Recurrent Prostate Cancer with Volumetric Modulated Arc Therapy (Vmat).
    Int J Radiat Oncol Biol Phys. 2019 Feb 27. pii: S0360-3016(19)30285.
    PubMed     Abstract available


  192. POTTERS L, Rana Z, Lee L, Cox BW, et al
    Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase I/II trial for Patients with Low and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 2. pii: S0360-3016(19)30183.
    PubMed     Abstract available


    January 2019
  193. ZELEFSKY MJ, Kollmeier M, McBride S, Varghese M, et al
    5-Year Outcomes of a Phase I Dose Escalation Study Using Stereotactic Body Radiosurgery for Patients with Low and Intermediate Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Jan 3. pii: S0360-3016(18)34227.
    PubMed     Abstract available


    December 2018
  194. VIDETIC GM, Paulus R, Singh AK, Chang JY, et al
    Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Dec 1. pii: S0360-3016(18)34048.
    PubMed     Abstract available


    November 2018
  195. ALAYED Y, Cheung P, Vesprini D, Liu S, et al
    SABR in high risk prostate cancer: outcomes from two prospective clinical trials with and without elective nodal irradiation.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33997.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neurosurgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: